Deborah M. Stephens,
DO
Languages Spoken: English, Spanish
Languages Spoken: English, Spanish
Deborah Stephens, DO joined the Division of Hematology and Hematologic Malignancies as an Assistant Professor in 2014. She completed her internal medicine residency at Cleveland Clinic and fellowship training at Ohio State University. Dr. Stephens’s clinic focuses on patients with chronic lymphocytic leukemia (CLL) and lymphoma. Her primary research interests include developing new targeted therapies for patients with CLL and lymphoma, studying resistance to current therapies, and developing supportive therapies for complications of CLL.. She is the Physician Leader of the Hematology Clinical Trials Division at Huntsman Cancer Institute and is the principal investigator on multiple clinical trials there. Her research has been widely published in influential journals such as the New England Journal of Medicine, Journal of Clinical Oncology, and Blood. She is a member of the editorial board for the Journal of Clinical Oncology. On a national level, she is an expert panelist for the National Comprehensive Cancer Network (NCCN) CLL Guidelines Panel, which establishes and published the most widely referenced guidelines for the evaluation and treatment of patients with CLL. Dr. Stephens is the Physician Leader of the SWOG CLL Working Group Committee, which is a group of CLL experts from academic centers around the country who plan and implement national clinical trials to improve the standard-of-care for CLL patients across the country. Dr. Stephens is also a member of the medical board for the CLL Society, which is the largest patient-led CLL group in the country. The sum of Dr. Stephens's experiences demonstrate her deep commitment to improve the care of patients with CLL and lymphoma.
Specialties
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Assistant Professor |
| Academic Divisions | Hematology/BMT |
| Board Certification | American Board of Internal Medicine (Sub: Hematology) American Board of Internal Medicine (Sub: Medical Oncology) |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.9/ 5
Care provider's explanation of condition/problem
4.9/ 5
Care provider's effort to include me in decisions
4.9/ 5
Wait time at clinic
4.2/ 5
Care provider's concern for questions & worries
4.9/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
February 26, 2021
HUNTSMAN CANCER CENTER
Dr Stephen's is an exceptional caregiver: top in her field, listens to the patient, clear in discussing care options and in answering questions. She has a good sense of humor and takes all the need time for the patient and she is supported with the incredible resources The Huntsman has to offer.
UofU Patient
January 28, 2021
HUNTSMAN CANCER CENTER
I've never had such professional compassion care
UofU Patient
January 17, 2021
HUNTSMAN CANCER CENTER
Doctor Deborah Stephens is a gifted, caring, intelligent Doctor and an even better compassionate women. I literally have quick grown to totally trust her in providing me the best care and options for treatment when the time comes. I consider this more than just a coincidence.
UofU Patient
January 07, 2021
HUNTSMAN CANCER CENTER
very pleased
UofU Patient
December 24, 2020
HUNTSMAN CANCER CENTER
best care around
UofU Patient
December 17, 2020
HUNTSMAN CANCER CENTER
good
UofU Patient
December 14, 2020
HUNTSMAN CANCER CENTER
You all are "AWESOME"
UofU Patient
December 05, 2020
HUNTSMAN CANCER CENTER
They are all great to work with.
UofU Patient
December 01, 2020
HUNTSMAN CANCER CENTER
Dr. Stephens is amazing! She is very caring and knowledgeable. In addition, she takes the time to answer all my questions and includes me in decisions. I have complete confidence in her care and I highly recommend her to others.
UofU Patient
November 29, 2020
HUNTSMAN CANCER CENTER
Dr. Stephen's is outstanding!
UofU Patient
November 17, 2020
HUNTSMAN CANCER CENTER
they were very rhoroufh
UofU Patient
October 11, 2020
HUNTSMAN CANCER CENTER
If all doctors were as good as Doctor Stephens all patients would have great care.
UofU Patient
October 09, 2020
HUNTSMAN CANCER CENTER
only the very best
UofU Patient
October 04, 2020
HUNTSMAN CANCER CENTER
Dr Stephens is great. She works with me, not on me.
UofU Patient
August 30, 2020
HUNTSMAN CANCER CENTER
Doctor Stephens is agreat care provider. Thanks
UofU Patient
August 16, 2020
HUNTSMAN CANCER CENTER
Deborah Stephens is the best care provider I've ever been to . All her patients are blessed by being in her care.
UofU Patient
August 10, 2020
HUNTSMAN CANCER CENTER
Renee Vadenpour (sp), DNP and Deborah Stephens, DO, Hematology and Oncology, are the consummate professionals. Each is caring, supportive and highly regarded by this patient.
UofU Patient
August 10, 2020
HUNTSMAN CANCER CENTER
Very caring and informative
UofU Patient
August 02, 2020
HUNTSMAN CANCER CENTER
Excellent care! Competent, understanding, clear and reasoned path forward.
UofU Patient
July 23, 2020
HUNTSMAN CANCER CENTER
good
UofU Patient
June 28, 2020
HUNTSMAN CANCER CENTER
This was first visit. Of course I was fearful and probably asked a lot of not especially well-informed questions. I was dealt with most professionally, courteously and patiently.
UofU Patient
June 28, 2020
HUNTSMAN CANCER CENTER
I love this team of doctors. It was good to see Dr Stephens and Renee. I feel they really care.
UofU Patient
June 21, 2020
HUNTSMAN CANCER CENTER
they were able to give all the options available.
UofU Patient
June 21, 2020
HUNTSMAN CANCER CENTER
Dr Stephens was awesome. she listened and she explained things in terms i could understand
UofU Patient
June 17, 2020
HUNTSMAN CANCER CENTER
Dr Stephens was very thorough in answering questions about my condition.
UofU Patient
June 05, 2020
HUNTSMAN CANCER CENTER
Natalie and Dr. Stephens are wonderful
UofU Patient
May 22, 2020
HUNTSMAN CANCER CENTER
Dr Stephens and nurse Renee are just the best!!!!!!
UofU Patient
April 12, 2020
HUNTSMAN CANCER CENTER
Dr Stephens is always caring and listening
UofU Patient
March 22, 2020
HUNTSMAN CANCER CENTER
She truly is the best doctor I have had the pleasure to meet in my long medical history. And I have been fortunate to know many great people along the way.She has a sincere reality about her manner . The way she administers seems like she is a friend, a classmate, coworker or cousin, someone close enough so you feel comfortable around her. She remembers details about your life. She doesnt speak down or brush of questions/concerns. she is pleasant which is always a bonus for patients who are struggling with the disease, who might be fearful, panicked, or hopeless. There are also times when she might be having a day as well, stress or whatever. She doesnt hide it, she is honest. I like that. Yet she also doesnt let it get in the way of her care of the patient, so even still she shines through.
UofU Patient
January 12, 2020
HUNTSMAN CANCER CENTER
Dr Stephens is a wonderful doctor, friendly, caring, and compassionate.
UofU Patient
January 11, 2020
HUNTSMAN CANCER CENTER
I appreciate everyone taking the time for questions and answers and concerns. I didn't feel rushed.
UofU Patient
January 10, 2020
HUNTSMAN CANCER CENTER
She is always explaining in detail, listening to and answering concerns.
UofU Patient
December 20, 2019
HUNTSMAN CANCER CENTER
Both Stephens and Lowrance are fabulous to work with.
UofU Patient
December 11, 2019
HUNTSMAN CANCER CENTER
good
UofU Patient
December 04, 2019
HUNTSMAN CANCER CENTER
Dr. Stephens is very attentive and listens to my concerns. I hope I never have to refer or recommend anyone else but will do so without hesitation if it is necessary.
UofU Patient
November 15, 2019
HUNTSMAN CANCER CENTER
I always have excellent care. I
UofU Patient
November 07, 2019
HUNTSMAN CANCER CENTER
Dr Stephens is an amazing physician. She is extremely knowledgeable regarding CLL, very professional and yet very patient as she listened to my and my wife's concerns regarding my illness. She patiently explained lab results and tests very clearly and answered all our questions. In addition, she is a very kind and caring doctor. We are very blessed to have her as our physician!
UofU Patient
October 25, 2019
HUNTSMAN CANCER CENTER
I'm so grateful for Doctor Stephens
UofU Patient
October 11, 2019
HUNTSMAN CANCER CENTER
The staff and doctors make a great effort to consider and respond to my concerns in a way that indicates that they have a genuine concern for my well being.
UofU Patient
September 25, 2019
HUNTSMAN CANCER CENTER
Doctor Stephens and her PA are very very good.
UofU Patient
September 20, 2019
HUNTSMAN CANCER CENTER
Very good
UofU Patient
August 23, 2019
HUNTSMAN CANCER CENTER
Dr Stephens and her staff have always been wonderful to us. I feel like the care she has given me was the best available.
UofU Patient
August 16, 2019
HUNTSMAN CANCER CENTER
Dr. Stephens is my heroine. She is supportive and very knowledgeable.
UofU Patient
July 26, 2019
HUNTSMAN CANCER CENTER
She is my angel.
UofU Patient
June 19, 2019
HUNTSMAN CANCER CENTER
It was very hard when our previous oncologist moved but we feel extremely blessed to be referred to Dr Stephens. Her primary focus is CLL and researching therapies to treat it. Since it was my first visit, she spent a lot of time asking questions about my health and did a great job of explaining a plan of action. In addition, she spent the time to research and refer me to another team of physicians to get a 2nd opinion on my 2nd health issue. She is very kind, patient and answered all our questions.
UofU Patient
June 19, 2019
HUNTSMAN CANCER CENTER
The team of Dr. Stephens and the NP Natalie Turner are the best care providers I've ever experienced. They are very informative and take time to answer my questions.
UofU Patient
June 07, 2019
HUNTSMAN CANCER CENTER
I love Dr. Stephens and her NP, Natalie. They are kind and compassionate and take their time with me.
UofU Patient
June 06, 2019
HUNTSMAN CANCER CENTER
great
UofU Patient
May 27, 2019
HUNTSMAN CANCER CENTER
This was my second appointment with Dr. Debbie Stephens. Like the first time, she was professional, knowledgeable about my condition and her advise gave me a great deal of comfort
UofU Patient
May 25, 2019
HUNTSMAN CANCER CENTER
Dr Stephens was excellent.
UofU Patient
May 18, 2019
HUNTSMAN CANCER CENTER
Dr Stephens is the best ever!!!!
UofU Patient
May 07, 2019
HUNTSMAN CANCER CENTER
I was very nervous while sitting in the exam room. Dr. Stevens took time and explained things in language I could understand.
UofU Patient
May 04, 2019
HUNTSMAN CANCER CENTER
Dr Stephens was behind schedule and s bit rushed compared to previous visits
UofU Patient
May 03, 2019
HUNTSMAN CANCER CENTER
We love Renee and this is our firsts time meeting Dr Stevens. We are pleased and feel we can continue with good care.
UofU Patient
April 05, 2019
HUNTSMAN CANCER CENTER
They listened to and were able to arrange for a request to have my blood work done locally and have the info sent to them. I live a considerable distance away and that is very appreciated.
UofU Patient
April 01, 2019
HUNTSMAN CANCER CENTER
provider is excellent in every way possible
UofU Patient
February 22, 2019
HUNTSMAN CANCER CENTER
very good
UofU Patient
February 12, 2019
HUNTSMAN CANCER CENTER
Doctor Stephens is a wonderful, brilliant physician and my life is blessed by her care.
UofU Patient
January 26, 2019
HUNTSMAN CANCER CENTER
excellent
UofU Patient
December 21, 2018
HUNTSMAN CANCER CENTER
Dr. Sthens is the best medical provider I have had
UofU Patient
December 05, 2018
HUNTSMAN CANCER CENTER
care by both Dr Stephens an NP's is outstanding-they are very helpful answering questions and providing info. The CLL forum they held to educate patients was a great addition to their care
UofU Patient
December 01, 2018
HUNTSMAN CANCER CENTER
I enjoy working with Dr. Stephens. She explains everything in a manner that is very understandable. Even though I travel 300 miles for each visit -- it is worth every mile.
UofU Patient
November 20, 2018
HUNTSMAN CANCER CENTER
I was impressed with the knowledge and caring of the care provider. I came with a full sheet of questions and every one was addressed to my complete understanding.
UofU Patient
November 09, 2018
HUNTSMAN CANCER CENTER
There seemed to be a lack of genuine concern for my concerns
UofU Patient
November 02, 2018
HUNTSMAN CANCER CENTER
Dr. Stevens is one amazing doctor. Dr. Stevens cares about you and is calm, informative, simple in her explanation.
UofU Patient
October 19, 2018
HUNTSMAN CANCER CENTER
excellent. outstanding
UofU Patient
October 05, 2018
HUNTSMAN CANCER CENTER
Dr Stephens is my doctor and she is amazing. Very knowledgeable, caring and friendly. Recommend her all the time for friends dealing with lymphoma.
UofU Patient
August 02, 2018
HUNTSMAN CANCER CENTER
Could not be more pleased
UofU Patient
July 20, 2018
HUNTSMAN CANCER CENTER
Communication with the patient is a big deal. We are full of stress and need know Lab results, explanations, treatment plans, prognosis, etc. I have been to SCA and City of Hope. You have the best Care providers, especially Dr Stephens.
UofU Patient
July 13, 2018
HUNTSMAN CANCER CENTER
You need a scale that goes to 10 for rating my confidence in Dr Stephens.
UofU Patient
July 10, 2018
HUNTSMAN CANCER CENTER
Dr.Stephens is a good Doctor, but the person she was training was misinformed and had poor bed side manner
UofU Patient
June 18, 2018
I would recommend Dr. Stephens in a heartbeat! Rarely have I had so much confidence in the quality and professionalism of my care provider!
UofU Patient
June 16, 2018
Dr. Stephens and Natalie are the very best
UofU Patient
June 08, 2018
Dr. Stephens is the best doctor ever...very helpful and spot on for treating my CLL and trust me I have seemed other providers you can tell she has genuine concern for you ...Thanks Doc for all you do for your patients
UofU Patient
May 31, 2018
This was one of the best health care visits I've ever had. Both NP & DR were extremely helpful, informative and thorough in answering my many questions.
UofU Patient
May 31, 2018
I like everything about Dr Stephens. It's unlikely I'd recommend her to anyone since IA don't know anyone else with leukemia.
UofU Patient
May 27, 2018
Deborah Stephens, like Dr. Lowrance in Urology, is great with patient experience - in terms of listening closely to patient concerns, explaining things in lay language when possible, and a kind, caring nature.
UofU Patient
May 12, 2018
very happy with the doctor
UofU Patient
April 19, 2018
I saw Ranae V, Dr. Stephens NP (don't remember he last name). She was very efficient and answered all my questions.
UofU Patient
April 15, 2018
dr Stephens and her PA treated my husband as if he was the only patient that day. wonderful.
UofU Patient
December 07, 2017
well educated, great bed sidemanners
UofU Patient
November 30, 2017
I like Dr. Stephens little pictures and diagrams she draws.
UofU Patient
November 10, 2017
Dr. Stephens is the very best ever!!
UofU Patient
October 31, 2017
Dr. Stephens is the essence of great medical care. Compassionate, very knowledgeable, caring, great follow through. She's a doctor's doctor.
UofU Patient
October 20, 2017
this is a great caring place to come.
UofU Patient
September 29, 2017
We were given some very informative information. We were very pleased with the care and information given.
UofU Patient
September 17, 2017
Dr. Stephens is the best & I trust my CLL care to no one else.
UofU Patient
August 25, 2017
Dr Stephens is an incredible and caring doctor.
UofU Patient
August 24, 2017
I am blessed to be at Huntsman. Fantastic care and fantastic facility.
UofU Patient
August 11, 2017
Dr Stephens and nurse Vadeboncoeur are the absolute best!!!!!!!
UofU Patient
August 06, 2017
Doctor went through what she could without test results. I was not as prepared with my questions.
UofU Patient
August 04, 2017
I really like working with Dr Stephens. She's pleasant and knowledgeable. She takes the time to explain my test results and lets me know what my options are regarding treatment. I am very satisfied with the care that I get from Dr. Stephens.
UofU Patient
July 24, 2017
the assistant and doctor are excellant
UofU Patient
June 16, 2017
so glad to have Dr. Stephens as my doctor.
UofU Patient
June 09, 2017
Ignorance arrogance power by lack of understanding
UofU Patient
June 09, 2017
Finding a good oncologist is REALLY important and the process can be an anxious one. What if you pick somebody that doesn't make you feel confident in their abilities. I feel extremely fortunate to have found Dr. Stephens. You can tell she knows her stuff, she explains things well. She seemed willing to take all the time necessary to answer all my questions and put me at ease. She is, frankly, an answer to prayers.
UofU Patient
May 25, 2017
The dr and her assistant both spent quality time in explaining condition. they both had very good bed-side manner!
UofU Patient
May 02, 2017
Best caring doctor.
UofU Patient
April 14, 2017
Dr Stephens is one of the best physicians I have associated with. She is thorough, knowledgeable and very easy to talk to. She takes the time to really listen to your needs and explains things in very basic terms. She deals with our Dr in St George. We are so grateful for her expertise and care.
UofU Patient
March 23, 2017
I am very impressed with the care and concern that Dr. Stephens has. She truly listened and answered everything we asked her and explained things to us to help us cope with what was a very stressful time for us.
UofU Patient
March 09, 2017
the Doctors are extremely good and caring; I have the utmost confidence in Dr. Stephens and her team
UofU Patient
March 04, 2017
Best Care In the World !
UofU Patient
March 03, 2017
all of the providers were excellent.
UofU Patient
February 16, 2017
Dr. Stephens is incredible; I feel fortunate to have her as my physician.
UofU Patient
February 02, 2017
Dr Stevens is a person I have entrusted my life to in helping deal with my illness .. no words to fully describe that ..
UofU Patient
January 12, 2017
Dr Stephens is an excellent Dr. I have had nothing but a positive experience as her patient and have told many people about her, people that are in need of a good cancer physician. She diagnosed my lymphoma back in August 2016, when several other Drs were unable to determine the cause of my illness.
UofU Patient
January 12, 2017
Dr. Stephens is the best ever. I can't say enough good about her and her patient interface.
UofU Patient
January 09, 2017
Dr. Stephens, Renee and the nursing staff made an otherwise difficult time in our lives much more bearable and nurturing.
UofU Patient
December 23, 2016
Dr. Stephens is an excellent physician and we feel fortunate to have her as my care giver.
UofU Patient
December 20, 2016
There couldn't be a better caring physician than Dr. Stevens. Superlative!
UofU Patient
December 02, 2016
Dr. Stephens took so much time with me and was very caring. My husband & I were very impressed.
UofU Patient
December 01, 2016
Extremely Positive Experience!
UofU Patient
November 11, 2016
Received more explicit information concerning my condition, in this single visit, than I have been able to receive from my original oncologist back east in 4 years .. I will be able to answer Q4 & Q5 in depth after my next visit ..
UofU Patient
November 11, 2016
I think Dr Stephens is great. I have confidence in her.
UofU Patient
October 28, 2016
I love Dr. Stephens and feel very fortunate that she is my physician. I have always felt she personally cares about me as a patient and as a person. She has broken the barrier of physician and patient and our conversations are easy and comfortable because of her personality and style. She is a great physician and I'm lucky to have found her!
UofU Patient
October 28, 2016
I don't believe I could have found a doctor and staff more concerned, competent, and reassuring
UofU Patient
September 23, 2016
Dr. Stevens listened and recommend and went along with what I decided for my care at this time.
UofU Patient
September 17, 2016
Dr. Stephens, Dr. Green and each member of her team were very professional, caring and encouraging at this difficult time.
UofU Patient
September 10, 2016
Dr Stephens is an incredible physician. She's the one that found our problem, and has been so kind and so straightforward with us about the diagnosis and prognosis. We feel so fortunate to have her as the physician who handled our case. We had been 4-5 months trying to find the cause of my problem, and she was so knowledgeable about lymphoma, and knew what needed to be done.
UofU Patient
August 22, 2016
I feel profoundly fortunate to have been assigned to Dr. Deborah Stephens as my oncologist. She is naturally very calming, reassuring and clear in all she reviews with me. I couldn't ask for better care!
UofU Patient
August 21, 2016
I love Dr. Stephen's and her whole team. There is no doubt how much they care. I am lucky to have them.
UofU Patient
July 26, 2016
I am so impressed with Dr. Deborah Stephens. She even called me to let me know about other tests she was scheduling so I wouldn't be surprised. How great is that?
UofU Patient
July 18, 2016
Dr. Stephens is an amazingly supportive care provider. Dr. Stephens nursing staff, most outstanding, from our point of view, is Martie. Martie has, at times, such as the last visit, to make accommodation for a "tardy" patient. kudos to all involved for their help.
UofU Patient
June 21, 2016
excellent experience
UofU Patient
April 19, 2016
very good
UofU Patient
April 01, 2016
I am very comfortable with Dr Stephens knowledge.
UofU Patient
March 26, 2016
Dr. Stephens surpassed all of my expectations. She spent a long time going over everything.
UofU Patient
March 25, 2016
Dr. Stephens is a wonderful doctor. I could not recommend her highly enough
UofU Patient
March 25, 2016
all of the assistants, nurses, and All of the assistants, nurses and Dr. Stephens were wonderful and took the time to help us understand, what was needed and what would help.
UofU Patient
March 20, 2016
Dr. Stephens and her staff are outstanding. I feel that I am in excellent hands.
UofU Patient
March 04, 2016
The support staff and Dr. Stephens' staff, including Dr. Stephens, were exceptional.
UofU Patient
March 04, 2016
Dr. Stevens is wonderfully kind and calm. She brings a much appreciated influence of calmness, reassurance and helpfulness. My questions are always answered patiently, and she provides much appreciated information.
UofU Patient
February 12, 2016
All my questions were answered so that I could understand them and if I had to have the doctor or nurse repeat their answer it was fine with them.
UofU Patient
December 04, 2015
Dr. Stephens is profoundly kind, patient, warm and thorough. I could not ask for anyone better. Dr. Stephen's nurse assistant is also very kind and friendly. Both instill peace of mind regarding my care.
UofU Patient
November 23, 2015
I have complete confidence in the staff at the clinic2 and in Dr Deborah Stephens!!!!
UofU Patient
August 27, 2015
Dr. Stephens is an amazing doctor.
UofU Patient
August 07, 2015
took time to make sure my needs were met
UofU Patient
June 20, 2015
We are very grateful to be in the care of Dr. Stephens!
UofU Patient
June 19, 2015
Getting a diagnosis of cancer isn't easy but Dr. Stevens has made me feel much better about it. She is concerned and upbeat about promising new treatments.
UofU Patient
May 22, 2015
Dr Stephens was outstanding. We came here primarily for an second opinion and we could not have been more pleased. The doctor personally intervened to get all of the services we needed.
UofU Patient
May 22, 2015
I can't say enough about the support and upbeat atmosphere, especially when I was so worried. Very calming, and answered all my questions.
UofU Patient
May 17, 2015
Dr. Debra Stephens is a wonderful person and very informative. I feel very blessed to have her as my Physician. She is very kind and understanding. Thanks
UofU Patient
May 15, 2015
Excellent
UofU Patient
January 21, 2015
Dr. Stephens has been respectful and compassionate in her interactions with us. She has spent several hours with us answering our questions, encouraging our thought process and researching treatment options. We are so thankful she is working with us.
UofU Patient
January 14, 2015
Dr. Stephens has a great way of showing how much she cares for her patents in comforting during diagnosis, yet redirects in a positive manner. she is Amazing!
UofU Patient
December 22, 2014
I have been so pleased with Dr. Stephens. She has gone above and beyond to address my concerns and to provide information to my husband.
UofU Patient
November 29, 2014
The physician was excellent. We immediately related, spent time with me and did not rush me at all. We not only went over results and what she suspected was happening but put into place a game plan that I understood and could easily live with! She is EXCELLENT!
UofU Patient
November 19, 2014
My wife & I feel very fortunate to have been referred to Huntsman & Dr.Stevens. Our questions about my diagnosis were answered in a clear & caring manner & I'm confident as more questions & issues arise they will be answered in the same manner.
Languages Spoken: English, Spanish
Deborah Stephens, DO joined the Division of Hematology and Hematologic Malignancies as an Assistant Professor in 2014. She completed her internal medicine residency at Cleveland Clinic and fellowship training at Ohio State University. Dr. Stephens’s clinic focuses on patients with chronic lymphocytic leukemia (CLL) and lymphoma. Her primary research interests include developing new targeted therapies for patients with CLL and lymphoma, studying resistance to current therapies, and developing supportive therapies for complications of CLL.. She is the Physician Leader of the Hematology Clinical Trials Division at Huntsman Cancer Institute and is the principal investigator on multiple clinical trials there. Her research has been widely published in influential journals such as the New England Journal of Medicine, Journal of Clinical Oncology, and Blood. She is a member of the editorial board for the Journal of Clinical Oncology. On a national level, she is an expert panelist for the National Comprehensive Cancer Network (NCCN) CLL Guidelines Panel, which establishes and published the most widely referenced guidelines for the evaluation and treatment of patients with CLL. Dr. Stephens is the Physician Leader of the SWOG CLL Working Group Committee, which is a group of CLL experts from academic centers around the country who plan and implement national clinical trials to improve the standard-of-care for CLL patients across the country. Dr. Stephens is also a member of the medical board for the CLL Society, which is the largest patient-led CLL group in the country. The sum of Dr. Stephens's experiences demonstrate her deep commitment to improve the care of patients with CLL and lymphoma.
Academic Locations
School of Medicine
801-585-2626
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Assistant Professor |
| Academic Divisions | Hematology/BMT |
| Board Certification | American Board of Internal Medicine (Sub: Hematology) American Board of Internal Medicine (Sub: Medical Oncology) |
Education History
| Fellowship | The Ohio State University Medical Center Hematology & Oncology Chief Fellow |
| Residency | The Ohio State University Internal Medicine Resident |
| Residency | Cleveland Clinic Internal Medicine Resident |
| Professional Medical | Kansas City University of Medicine Osteopathic Medicine D.O. |
| Undergraduate | The University of Iowa Health Sciences B.S. |
Selected Publications - Journal Articles
Journal Article
- Byrd JC, Woyach JA, Furman RR, Martin P, OBrien S, Brown JR, Stephens DM, Barrientos J, Devereux S, Hillmen P, Pagel JM, Hamdy A, Izumi R, Patel P, Wang MH, Jain N, Wierda WG (2021). Acalabrutinib in Treatment-Naïve Chronic Lymphocytic Leukemia. (Epub ahead of print) Blood.
- Kittai AS, Huang Y, Gordon M, Denlinger N, Mian A, Fitzgerald L, Bishop J, Nagle S, Stephens DM, Jaglowski S, Hill B, Danilov AV (2020). Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter Analysis. Biol Blood Marrow Transplant, 27(1), 46-52.
- Stephens DM, Boucher K, Kander E, Parikh SA, Parry EM, Shadman M, Pagel JM, Cooperrider J, Rhodes J, Mato A, Winter A, Hill B, Gaballa S, Danilov A, Phillips T, Brander DM, Smith SM, Davids M, Rogers K, Glenn MJ, Byrd JC (2020). Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration. Haematologica, Online ahead of print.
- Persky DO, Li H, Stephens DM, Park SI, Bartlett NL, Swinnen LJ, Barr PM, Winegarden JD 3rd, Constine LS, Fitzgerald TJ, Leonard JP, Kahl BS, LeBlanc ML, Song JY, Fisher RI, Rimsza LM, Smith SM, Miller TP, Friedberg JW (2020). Positron Emission Tomography-Directed Therapy for Patients With Limited-Stage Diffuse Large B-Cell Lymphoma: Results of Intergroup National Clinical Trials Network Study S1001. J Clin Oncol, 38(26), 3003-3011.
- Koffman B, Mato A, Byrd J, Danilov A, Hedrick B, Ujjani C, Roeker L, Stephens DM, Davids M, Pagel JM, Shadman M (2020). A survey of CLL experts opinion on management of patients during the COVID-19 pandemic. J Clin Oncol, E199-E203..
- Byrd JC, Wierda WG, Schuh A, Devereux S, Chaves JM, Brown JR, Hillmen P, Martin P, Awan FT, Stephens DM, Ghia P, Barrientos J, Pagel JM, Woyach JA, Burke K, Covey T, Gulrajani M, Hamdy A, Izumi R, Frigault MM, Patel P, Rothbaum W, Wang MH, OBrien S, Furman RR (2018). Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results. Blood, 135(15), 1204-1213.
- Wierda WG, Byrd JC, Abramson JS, Bilgrami SF, Bociek G, Brander D, Brown J, Chanan-Khan AA, Chavez JC, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, Kaplan LD, Khan N, Kipps TJ, Lim MS, Ma S, Malek S, Mato A, Mosse C, Shadman M, Siddiqi T, Stephens D, Sundaram S, Wagner N, Dwyer MA, Sundar H (2020). Chronic lymphocytic leukemia/small lymphocytic lymphoma, Version 4.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 18(2), 185-217.
- Gordon MJ, Sitlinger A, Salous T, Alqahtani H, Churnetski M, Rivera X, Wisniewski P, Cohen J, Patel K, Shadman M, Choi M, Hill B, Stephens DM, Persky D, Brander D, Danilov AD (2020). A simplified prognostic index for chronic lymphocytic leukemia treated with ibrutinib: results from a multicenter retrospective cohort study. Leuk Res Treatment, 89.
- Stephens DM (2019). Venetoclax and obinutuzumab for frontline treatment of chronic lymphocytic leukemia. Blood, 134(20), 1691-1696.
- Stephens DM, Li H, Schder H, Straus DJ, Moskowitz CH, LeBlanc M, Rimsza LM, Bartlett NL, Evens AM, LaCasce AS, Barr PM, Knopp MV, Hsi ED, Leonard JP, Kahl BS, Smith SM, Friedberg JW (2019). Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma. Blood, 134(15), 1238-1246.
- Geer M, Roberts E, Shango M, Till BG, Smith SD, Abbas H, Hill BT, Kaplan J, Barr PM, Caimi P, Stephens DM, Lin E, Herrera AF, Rosenbaum E, Amengual JE, Boonstra PS, Devata S, Wilcox RA, Kaminski MS, Phillips TJ (2019). Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United States. Br J Haematol, 186(2), 255-262.
- Awan FT, Schuh A, Brown JR, Furman RR, Pagel JM, Hillmen P, Stephens DM, Woyach J, Bibikova E, Charuworn P, Frigault MM, Hamdy A, Izumi R, Linghu B, Patel P, Wang MH, Byrd JC (2018). Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib. Blood Adv, 3(9), 1553-1562.
- Stephens DM, Byrd JC (2019). How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia. Blood, 133(12), 1298-1307.
- Stephens DM (2019). Highs and lows of minimal residual disease in CLL. Blood, 133(5), 386-388.
- Havard R, Stephens DM (2018). Anti-CD19 Chimeric Antigen Receptor T Cell Therapies: Harnessing the Power of the Immune System to Fight Diffuse Large B Cell Lymphoma. Curr Hematol Malig Rep, 13(6), 534-542.
- Wierda WG, Byrd JC, Abramson JS, Bhat S, Bociek G, Brander D, Brown J, Chanan-Khan A, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, Kaplan LD, Khan N, Kipps TJ, Lancet J, Ma S, Malek S, Mosse C, Shadman M, Siddiqi T, Stephens D, Wagner N, Zelenetz AD, Dwyer MA, Sundar H (2017). Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 15, 1414-1427.
- Giulino-Roth L, ODonohue T, Chen Z, Bartlett NL, LaCasce A, Martin-Doyle W, Barth MJ, Davies K, Blum KA, Christian B, Casulo C, Smith SM, Godfrey J, Termuhlen A, Oberley MJ, Alexander S, Weitzman S, Appel B, Mizukawa B, Svoboda J, Afify Z, Pauly M, Dave H, Gardner R, Stephens DM, Zeitler WA, Forlenza C, Levine J, Williams ME, Sima JL, Bollard CM, Leonard JP (2017). Outcomes of adults and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R. Br J Haematol, 179(5), 739-747.
- Stephens DM (2017). Brentuximab: is it time for a new "B" in ABVD? Blood, 130(11), 1281-1282.
- Haverkos BM, Abbott D, Hamadani M, Armand P, Flowers ME, Merryman R, Kamdar M, Kanate AS, Saad A, Mehta A, Ganguly S, Fenske TS, Hari P, Lowsky R, Andritsos L, Jagasia M, Bashey A, Brown S, Bachanova V, Stephens D, Mineishi S, Nakamura R, Chen YB, Blazar BR, Gutman J, Devine SM (2017). PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD. Blood, 130(2), 221-228.
- Awan FT, Schuh A, Brown JR, Furman RR, Pagel JM, Hillmen P, Stephens DM, Woyach J, Bibikova E, Charuworn P, Frigault MM, Hamdy A, Izumi R, Linghu B, Patel P, Wang MH, Byrd JC (2016). Acalabrutinib monotherapy in patients with ibrutinib intolerance: results from the phase 1/2 ACE-CL-001 clinical study. Blood, 128(22), 638.
- Vrontikis A, Carey J, Gilreath JA, Halwani A, Stephens DM, Sweetenham JW (2016). Proposed Algorithm for Managing Ibrutinib-Related Atrial Fibrillation. Oncology (Williston Park), 30(11), 970-4, 980-1, C3.
- Haverkos BM, Schowinksy J, Kaplan J, Kamdar M, Kanate AS, Saad A, Mehta A, Ganguly S, Flowers MED, Fensky TS, Hari P, Hamadani M, Lowsky R, Andritsos L, Jagasia MH, Brown S, Armand P, Merryman RW, Bachanova V, Stephens DM, Nakamura R, Gutman JA, Devine SM (2016). Checkpoint Blockade for Treatment of Relapsed Lymphoma Following Allogeneic Hematopoietic Cell Transplant: Use May be Complicated By Onset of Severe Acute Graft Versus Host Disease. Blood, 128(22), 1163.
- Stephens DM, Li H, LeBlanc ML, Puvvada SD, Persky D, Friedberg JW, Smith SM (2016). Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736. J Clin Oncol, 34(25), 2997-3004.
- Luo C, Deng Z, Li L, Clayton F, Chen AL, Wei R, Miles R, Stephens DM, Glenn M, Wang X, Jensen PE, Chen X (2016). Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cells. Oncotarget, 7(11), 12806-22.
- Byrd JC, Harrington B, OBrien S, Jones JA, Schuh A, Devereux S, Chaves J, Wierda WG, Awan FT, Brown JR, Hillmen P, Stephens DM, Ghia P, Barrientos JC, Pagel JM, Woyach J, Johnson D, Huang J, Wang X, Kaptein A, Lannutti BJ, Covey T, Fardis M, McGreivy J, Hamdy A, Rothbaum W, Izumi R, Diacovo TG, Johnson AJ, Furman RR (2016). Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia. N Engl J Med, 374(4), 323-32.
- Stephens DM, Ruppert AS, Weirda WG, Jones JA, Woyach JA, Maddocks K, Jaglowski SM, Andritsos LA, Flynn JM, Grever MR, Lozanski G, Tam C, OBrien S, Keating MJ, Muthusamy N, Abruzzo LV, Heerema NA, Byrd JC (2015). Externally validated predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients. Am J Hematol, 90(11), 967-9.
- Stephens DM, Spurgeon SE (2015). Ibrutinib in mantle cell lymphoma patients: glass half full? Evidence and opinion. Ther Adv Hematol, 6(5), 242-52.
- Miller CR, Stephens D, Ruppert AS, Racke F, McFaddin A, Breidenbach H, Lin HJ, Waller K, Bannerman T, Jones JA, Woyach JA, Andritsos LA, Maddocks K, Zhao W, Lozanski G, Flynn JM, Grever M, Byrd JC, Heerema NA (2015). Jumping translocations, a novel finding in chronic lymphocytic leukaemia. Br J Haematol, 170(2), 200-7.
- Rogers KA, Salem G, Stephens DM, Andritsos LA, Awan FT, Byrd JC, Flynn JM, Maddocks KJ, Huang Y, Ruppert AS, Jones JA (2015). A single-institution retrospective cohort study of patients treated with R-EPOCH for Richter’s transformation of chronic lymphocytic leukemia. Blood, 126(23), 2951.
- Stephens DM, Ruppert AS, Jones JA, Woyach J, Maddocks K, Jaglowski SM, Andritsos LA, Flynn JM, Grever MR, Lozanski G, Johnson AJ, Muthusamy N, Heerema NA, Byrd JC (2014). Impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center. Leukemia, 28(6), 1365-8.
- Cheney CM, Stephens DM, Mo X, Rafiq S, Butchar J, Flynn JM, Jones JA, Maddocks K, OReilly A, Ramachandran A, Tridandapani S, Muthusamy N, Byrd JC (2014). Ocaratuzumab, an Fc-engineered antibody demonstrates enhanced antibody-dependent cell-mediated cytotoxicity in chronic lymphocytic leukemia. mAbs, 6(3), 749-55.
- Stephens DM, Ruppert AS, Maddocks K, Andritsos L, Baiocchi R, Jones J, Johnson AJ, Smith LL, Zhao Y, Ling Y, Li J, Phelps MA, Grever MR, Byrd JC, Flynn JM (2013). Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemia. Leuk Res, 37(10), 1195-9.
- Stephens DM, Stark A, Jones JA, Woyach JA, Maddocks K, Jaglowski SM, Andritsos LA, Flynn JM, Grever MR, Lozanski G, Johnson AJ, Muthusamy N, Heerema NA, Byrd JC (2013). Changing the treatment paradigm for previously treated chronic lymphocytic leukemia patients with del(17p) karyotype. Blood, 122(21), 2872.
- Stephens DM, Byrd JC (2013). Chronic lymphocytic leukemia with del(17p13.1): a distinct clinical subtype requiring novel treatment approaches. Oncology (Williston Park), 26(11), 1044-54.
- Stephens DM, Ruppert AS, Blum K, Jones J, Flynn JM, Johnson AJ, Ji J, Phelps MA, Grever MR, Byrd JC (2012). Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach. Haematologica, 97(3), 423-7.
- Stephens DM, Ruppert AS, Blum K, Jones J, Flynn JM, Johnson AJ, Ji J, Phelps MA, Grever MR, and Byrd JC (03/01/2012). Flavopiridol treatment of patients aged 70 or older with refractory or relapsed chronic lymphocytic leukemia is a feasible and active therapeutic approach. Haematologica, 97(3), 423-427.
- Mickelson DM, Sproat L, Dean R, Sobecks R, Rybicki L, Kalaycio M, Pohlman B, Sweetenham J, Andresen S, Bolwell B, Copelan EA (2011). Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT. Bone Marrow Transplant, 46(1), 84-9.
- Mickelson DM, Hatem S, and Copelan E (02/01/2010). Granulocyte Simulating-Colony Factor-Associated Splenic Artery Rupture. Leuk Lymphoma, 51(2), 335-337.
Review
- Stephens DM, Byrd JC (2020). Next-Generation Bruton Tyrosine Kinase Inhibitors. [Review]. Am J Clin Oncol, JCO2001594.
- Shadman M, Stephens DM (2020). Debate: What is optimal first-line therapy for chronic lymphocytic leukemia? [Review]. J Natl Compr Canc Netw, 18(7.5), 993-997.
- Stephens DM, Byrd JC (2019). How I manage ibrutinib intolerance and complications in patients with chronic lymphocytic leukemia. . [Review]. Blood, 133(12), 1298-1307.
- Stephens DM, Smith SM (2018). Diffuse large B-cell lymphoma-Who should we FISH? [Review]. Ann Lymphoma, 2, 2616-2695.
- Voorhies BN, Stephens DM (2017). What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017? [Review]. Curr Treat Options Oncol, 18(2), 12.
- Stephens DM, Goodrich AL (2016). Risk-Stratified Treatment in Chronic Lymphocytic Leukemia. [Review]. J Adv Pract Oncol, 7(3), 314-317.
- Stephens DM, Sweetenham JW (04/11/2015). Clinical controversies of double-hit lymphoma. [Review]. Am J Hematol Oncol, 11(4), 10-16.
- Stephens DM, Byrd JC (2013). Improving the treatment outcome of patients with chronic lymphocytic leukemia through targeted antibody therapy. [Review]. Hematol Oncol Clin North Am, 27(2), 303-27.
- Stephens DM, Byrd JC (11/1/2012). Chronic lymphocytic leukemia with del(17p13.1): A distinct clinical subtype requiring novel treatment approaches. [Review]. Oncology, 11, 1044-1054.
- Stephens DM, Byrd JC (2012). Ask the hematologists: Is there a standard of care for treating older patients with chronic lymphocytic leukemia? [Review]. The Hematologist, 9(4), 4.
- Stephens DM, Byrd JC (2012). Chronic lymphocytic leukemia with del(17p13.1): a distinct clinical subtype requiring novel treatment approaches. [Review]. Oncology, 26(11), 1044-1054.
- Mickelson DM, Mady E, and Teng K (2009). A 43 year-old woman with chest pressure: a review of hypercoagulable states. [Review]. Cleve Clin J Med, 76(3), 191-8.
- Shah H, Stephens DM, Seymour J, Maddocks K (Pending). Incorporating novel targeted and immunotherapeutic agents in treatment of B-cell lymphomas. 2021 Feb. Accepted for publication. [Review]. Journal of Clinical Oncology.
Conference Proceedings
- Haverkos BM, Schowinksy J, Kaplan JB, Kamdar M, Kanate AS, Saad A, Ganguly S, Flowers M, Fenske TS, Hari P, Hamadani M, Lowsky R, Andritsos L, Jagasia M, Brown S, Armand P, Merryman R, Bachanova V, Stephens DM, Nakumura R, Gutman J, Devine SM (12/03/2016). Checkpoint blockade for treatment of lymphoma following allogeneic stem cell transplant: use may be complicated by onset of severe acute graft versus host disease. American Society of Hematology Meeting, San Diego.
- Stephens DM, Starodub AN, Byrd JC, Wegener, WA, Horne H, Goldenberg, DM, Christian BA (07/15/2016). Subcutaneous injections of IMMU-114 (anti-HLA-DR IgG4 monoclonal antibody): Initial results of a phase I first-in-man study in hematologic malignancies. Pan-Pacific Lymphoma Conference, Poipu, Hawaii.
- Byrd JC, Jones JA, Furman RR, Stephens DM, Devereux S, Brown JR, Hillmen P, Hamdy AM, Wang MH, Patel P, Mittag D, Krantz M, Rothbaum W, Izumi R, OBrien SM, Wierda WG (06/15/2016). Acalabrutinib, a second-generation Bruton tyrosine kinase inhibitor, in previously untreated chronic lymphocytic leukemia. American Society of Clinical Oncology Annual Meeting, Chicago.
- Stephens DM, Starodub AN, Byrd JC, Wegener, WA, Horne H, Goldenberg, DM, Christian BA (12/01/2015). Subcutaneous injections of IMMU-114 (anti-HLA-DR IgG4 monoclonal antibody): Initial results of a phase I first-in-man study in hematologic malignancies. Orlando, Florida: American Society of Hematology Meeting.
- Stephens DM, LeBlanc ML, Li H, Miller TP, Puvvada SD, Persky D, Friedberg J, Smith SM (06/19/2015). Continued risk of relapse independent of treatment modality in limted stage diffuse large B-cell lymphoma: Final and long-term analysis of SWOG study S8736. 13th International Conference on Malignant Lymphoma, Lugano, Switzerland.
- Stephens DM, Stark A, Jones JA, Woyach JA, Maddocks K, Jaglowski SM, Andritsos LA, Flynn JM, Grever MR, Lozanski G, Johnson AJ, Muthusamy N, Heerema NA, Byrd JC (2013). Changing the treatment paradigm for previously treated chronic lymphocytic leukemia patients with del(17p) karyotype. New Orleans, LA: American Society of Hematology Meeting.
- Stephens DM, Cheney CM, Mo X, Rafiq S, Butchar J, Flynn JM, Jones JA, Maddocks K, OReilly A, Ramachandran A, Tidandapani S, Muthusamy N, and Byrd JC (2013). Ocaratuzumab, a proposed effective and convenient alternative for treatment of chronic lymphocytic leukemia. Cologne, Germany: International Workshop on Chronic Lymphocytic Leukemia.
- Stephens DM, Ruppert AS, Woyach JA, Maddocks K, Jaglowski SM, Andritsos LA, Jones JA, Flynn JM, Grever MR, Hareema N, Muthusamy N, and Byrd JC (06/01/2013). Predictive clinical model for untreated del(17p13.1) chronic lymphocytic leukemia patients. Stockholm, Sweden: European Hematology Association International Congress.
- Stephens DM, Maddocks K, Andritsos L, Baiocchi R, Jones J, Phelps M, Johnson AJ, Smith L, Grever MR, Byrd JC, and Flynn JM (06/01/2012). Phase I feasibility trial of cyclophosphamide, alvocidib (flavopiridol) and rituximab in patients with high-risk b-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Amsterdam, Netherlands: European Hematology Association International Congress.
- Mickelson D, Sproat L, Dean R, Sobecks R, Rybicki L, Kalaycio M, Pohlman B, Sweetenham J, Andresen S, Bolwell B, and Copelan E (02/01/2009). T-cell engraftment kinetics following myeloablative and nonmyeloablative regimens for allogeneic hematopoietic stem-cell transplantation. Tampa, Florida: American Society for Blood and Marrow Transplantation.
Commentary
- Stephens DM (2017). Brentuximab: is it time for a new "B" in ABVD? Blood, 130(11), 1281-1282.
- Stephens DM (2016). Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia: An Archaic Intervention or a Necessary Evil? Oncology (Williston Park), 30(6), 539-40.
Case Report
- Fitzgerald L, Stephens DM (2020). Burkitt Lymphoma Presenting as Cranial Multineuritis Secondary to Primary Neurolymphomatosis: A Diagnostic Challenge. Clin Lymphoma Myeloma Leuk, 20(4), e201-e204.
- Laggis C, Miles R, Stephens DM, Duffy K, Bowen A, Wada D (2019). Cutaneous mantle cell lymphoma histomorphologically mimicking subcutaneous panniculitis-like T-cell lymphoma: Case report. J Cutan Pathol, 46(7), 538-541.
- Juster-Switlyk K, Smith AG, Kovacsovics T, Stephens D, Glenn M, Palmer CA, Quigley EP 3rd, Kolb N (2017). MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk. Neurology, 88(6), 603-604.
Letter
- Stephens DM, Schoder H, Li H, Friedberg J (2020). Reply: Interim PET Assessment of Advanced Hodgkin Lymphoma: Is It Sufficient? [Letter to the editor]. J Nucl Med, 61(11), 1695.
- Koffman B, Mato A, Byrd JC, Danilov A, Hedrick B, Ujjani C, Roeker L, Stephens DM, Davids MS, Pagel JM, Shadman M (2020). Management of CLL patients early in the COVID-19 pandemic: An international survey of CLL experts. [Letter to the editor]. Am J Hematol, 95(8), E199-E203.
Abstract
- Giulino-Roth L, ODonohue T, Chen Z, Bartlett NL, LaCasce A, Martin-Doyle W, Barth MJ, Davies K, Blum KA, Christian B, Casulo C, Smith SM, Godfrey J, Termuhlen A, Oberlye MJ, Alexander S, Weitzman S, Appel B, Mizukawa B, Svoboda J, Afify Z, Pauly M, Dave H, Gardner R, Stephens DM, Zeitler WA, Forlenza C, Levine J, Williams ME, Sima JL, Bollard CM, Leonard JP (2017). Outcomes of adults, adolescents, and children with primary mediastinal B-cell lymphoma treated with dose-adjusted EPOCH-R therapy: a multicenter retrospective analysis [Abstract]. Hematological Oncology, 35(S2), 61-2.
- Awan FT, Schuh A, Brown JR, Furman RR, Pagel JM, Hillmen P, Stephens DM, Hamdy A, Huang J, Izumi R, Patel P, Wang MH, Byrd JC (12/03/2016). Acalabrutinib monotherapy in patients with ibrutinibi: results from the phase 1/2 ACE-CL-001 clinical study [Abstract]. Blood, 128(22), 638.
- Stephens DM, Ruppert AS, Christian B, Jones J, Flynn JM, Porcu P, Baiocchi R, Byrd JC, Dotson EK, Crawford BS, and Blum KA (2012). Toxicity in patients 65 years with dose adjusted REPOCH for untreated diffuse large B cell lymphoma [Abstract]. Journal of Clinical Oncology, 30(suppl), 15.